Biotherapy monitoring, a major area of interest at the European Crohn's and Colitis Organisation (ECCO) Congress
![Data presented at ECCO congress supports switching from Remicade® to biosimilar infliximab - Hospital Pharmacy EuropeHospital Pharmacy Europe Data presented at ECCO congress supports switching from Remicade® to biosimilar infliximab - Hospital Pharmacy EuropeHospital Pharmacy Europe](https://hospitalpharmacyeurope.com/wp-content/uploads/2017/04/Gastroenterology-1.jpg)
Data presented at ECCO congress supports switching from Remicade® to biosimilar infliximab - Hospital Pharmacy EuropeHospital Pharmacy Europe
Gianluca Pellino on Twitter: "@EuroSurg 1 poster on at 11 ECCO Congress in Amsterdam. We are spreading! https://t.co/VnibnJrvlu" / Twitter
![Galapagos Reports Positive Phase 2 Trial Data of Crohn's Disease Drug Filgotinib at ECCO Congress - IBD News Today Galapagos Reports Positive Phase 2 Trial Data of Crohn's Disease Drug Filgotinib at ECCO Congress - IBD News Today](https://ibdnewstoday.com/wp-content/uploads/2016/03/shutterstock_392092564-375x475@2x.jpg)